Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized trial evaluating minocycline for Retinitis pigmentosa. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Retinal Dystrophy
• Retinitis Pigmentosa

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Retinitis Pigmentosa, Inherited Retinal Dystrophy | Phase 3 | Status: NOT_YET_RECRUITING